Veraxa Biotech Holding AG
Support and Resistance Levels
Past performance
News About VRXA
All events for VRXA
All deals for VRXA
Financial Ratios
Financial Statements
VRXA vs Sector & Peers
About Veraxa Biotech Holding AG
Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company was founded in 2021 and is based in Heidelberg, Germany. Website veraxa.com
Headquarters Heidelberg, ZH, DE